AI Apocalypse, Firmus IPO, and the Economics of Cheap Ozempic
As artificial intelligence development accelerates, financial markets brace for major public listings, and metabolic health therapeutics approach dramatic cost reductions, global economic and clinical landscapes face simultaneous transformation. In mid-September ... Read More